Research Article

A Pragmatic Pilot Cluster-Randomized Study of Tobacco Screening and Smoking Cessation Program for Community Pharmacies in Japan: FINE Program

Table 3

Backgrounds of smoking patients.

ParameterIntervention group (FINE program participants) ()Control group (usual program participants) ()

Mean (SD) age63.8 (8.17)58.3 (21.73)0.426
Male (%)83.350.00.193
Antihypertensive drugs (yes: %)50.033.30.168
Drugs for treating dyslipidemia75.08.30.002
Drugs for diabetes33.38.30.029
Inhaled drugs16.78.30.018
Smoking status (%)
 Traditional cigarettes91.775.00.122
 Heated-not-burn/electronic tobacco products0.025.0
 Both8.30.0
Mean (SD) amount consumed per day
 Traditional cigarettes14.8 (7.08)12.4 (5.90)0.423
 Heated-not-burn/electronic tobacco products15.0 (0.00)9.7 (8.51)0.642
Mean (SD) duration of smoking in years36.3 (14.5)32.4 (22.3)0.630
Stage of change (%)
 Indifference0.00.00.504
 Precontemplation33.38.3
 Contemplation25.033.3
 Preparation33.350.0
 Unknown8.38.3